# EXPAREL Infiltration in Subjects Undergoing Femoral Nerve Block With Bupivacaine HCl for Total Knee Arthroplasty

> **NCT02255500** · PHASE4 · COMPLETED · sponsor: **Pacira Pharmaceuticals, Inc** · enrollment: 23 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Bupivacaine FNB
- **DRUG:** EXPAREL Infiltration

## Key facts

- **NCT ID:** NCT02255500
- **Lead sponsor:** Pacira Pharmaceuticals, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2021-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02255500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02255500, "EXPAREL Infiltration in Subjects Undergoing Femoral Nerve Block With Bupivacaine HCl for Total Knee Arthroplasty". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02255500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*